Prevalence and predictors of the sub-target Hb level in children on dialysis

Nephrology Dialysis Transplantation

Volumn 27, Issue 10, 2012, Pages 3950-3957

  Van Stralen, Karlijn J ^a   Krischock, Leah ^b   Schaefer, Franz ^c   Verrina, Enrico ^d   Groothoff, Jaap W ^a   Evans, Jonathan ^e   Heaf, James ^f   Ivanov, Dimitar ^g   Kostic, Mirjana ^h   Maringhini, Silvio ⁱ   Podracká, Ludmila ^j   Printza, Nikoleta ^k   Pundziene, Birute ^l   Reusz, Gyorgy S ^m   Vondrak, Karel ⁿ   Jager, Kitty J ^a   Jane Tizard, E ^o  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d G GASLINI INSTITUTE   (Italy)

^e NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^f GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^g TARAS SHEVCHENKO NATIONAL UNIVERSITY OF KYIV   (Ukraine)

^h UNIVERSITY CHILDREN S HOSPITAL   (Serbia)

ⁱ 'G di Cristina' Children's Hospital   (Italy)

^j Med Faculty of Safarik University   (Slovakia)

^k ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^l LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^m SEMMELWEIS UNIVERSITY   (Hungary)

ⁿ UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^o BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

more..

Author keywords

anaemia; children; dialysis; Hb

Indexed keywords

ALBUMIN; ANTIANEMIC AGENT; FERRITIN; HEMOGLOBIN; IRON; PARATHYROID HORMONE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC GROUP; EUROPEAN; FERRITIN BLOOD LEVEL; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFANT; KIDNEY MALFORMATION; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; METABOLIC DISORDER; PERITONEAL DIALYSIS; PREDICTION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; URINARY TRACT MALFORMATION;

ADOLESCENT; AGE FACTORS; ANEMIA; BLOOD PRESSURE; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; EUROPE; FEMALE; FERRITINS; HEMATINICS; HEMOGLOBINS; HUMANS; INFANT; IRON; KIDNEY FAILURE, CHRONIC; MALE; PARATHYROID HORMONE; REGISTRIES; RENAL REPLACEMENT THERAPY; SERUM ALBUMIN;

EID: 84868518131     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs178     Document Type: Article

References (39)

1. Koshy SM, Geary DF. Anemia in children with chronic kidney disease. Pediatr Nephrol 2008; 23: 209-219
2. Chavers BM, Roberts TL, Herzog CA et al. Prevalence of anemia in erythropoietin-treated pediatric as compared to adult chronic dialysis patients. Kidney Int 2004; 65: 266-273
3. Gouva C, Nikolopoulos P, Ioannidis JP et al. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int 2004; 66: 753-760
4. Locatelli F, Pisoni RL, Combe C et al. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004; 19: 121-132
5. Amaral S, Hwang W, Fivush B et al. Association of mortality and hospitalization with achievement of adult hemoglobin targets in adolescents maintained on hemodialysis. J Am Soc Nephrol 2006; 17: 2878-2885
6. Gerson A, Hwang W, Fiorenza J et al. Anemia and health-related quality of life in adolescents with chronic kidney disease. Am J Kidney Dis 2004; 44: 1017-1023
7. Morris KP, Skinner JR, Hunter S et al. Short term correction of anaemia with recombinant human erythropoietin and reduction of cardiac output in end stage renal failure. Arch Dis Child 1993; 68: 644-648
8. Richardson D, Ford D, Gilg J et al. UK Renal Registry 11th Annual Report (December 2008): Chapter 9 Haemoglobin, ferritin and erythropoietin amongst patients receiving dialysis in the UK in 2007: national and centre-specific analyses. Nephron Clin Pract 2009; 111 (Suppl 1): c149-c183
9. KDOQI. Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 2006; 47: S11-S145
10. The National Clinical Guideline Centre. Anaemia management in Chronic Kidney Disease. Commissioned by the National Institute for Health and Clinical Excellence, 2011. http://www.nice.org.uk/nicemedia/live/13329/52851/52851.pdf
11. Locatelli F, Aljama P, Canaud B et al. Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to reduce cardiovascular events with Aranesp therapy (TREAT) study. Nephrol Dial Transplant 2010; 25: 2846-2850
12. Locatelli F, Aljama P, Barany P et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 2004; 19(Suppl 2): ii1-ii47
13. Strippoli GF, Craig JC, Manno C et al. Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials. J Am Soc Nephrol 2004; 15: 3154-3165
14. Tonelli M, Winkelmayer WC, Jindal KK et al. The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patients. Kidney Int 2003; 64: 295-304
15. Schroder CH. The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee. Pediatr Nephrol 2003; 18: 805-809
16. US Food and Drug Administration. http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm260670.htm (24 June 2011, date last accessed)
17. Tizard EJ, Verrina E, van Stralen K et al. Progress with the European Society for Paediatric Nephrology (ESPN)/ERA-EDTA Registry for children with established renal failure (ERF). Nephrol Dial Transplant 2009; 24: 2615-2617
18. von Elm E, Altman DG, Egger M et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-1457
19. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114(2 Suppl 4th Report): 555-576
20. van Stralen KJ, Jager KJ, Schaefer F et al. Suggested revision of the NHBPEP blood pressure standardization for growth retarded children. Pediatr Nephrol 2011; 26: 819-820
21. Kuczmarski RJ, Ogden CL, Guo SS et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11 2002; 246: 1-190.
22. ERA-EDTA registry. ERA-EDTA Registry Annual Report 2007. Academic Medical Center, Department of Medical Informatics, Amsterdam, The Netherlands, 2009
23. The National Clinical Guideline Centre. Nice Guidelines-Anaemia Management in Chronic Kidney Disease. The Royal College of Physicians, London, 2006.
24. Fadrowski JJ, Frankenfield D, Amaral S et al. Children on long-term dialysis in the United States: findings from the 2005 ESRD clinical performance measures project. Am J Kidney Dis 2007; 50: 958-966
25. Smith LB, Fadrowski JJ, Howe CJ et al. Secondary hyperparathyroidism and anemia in children treated by hemodialysis. Am J Kidney Dis 2010; 55: 326-334
26. Leonard MB, Donaldson LA, Ho M et al. A prospective cohort study of incident maintenance dialysis in children: an NAPRTC study. Kidney Int 2003; 63: 744-755
27. Atkinson MA, Martz K, Warady BA et al. Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS. Pediatr Nephrol 2010; 25: 1699-1706
28. Frankenfield DL, Neu AM, Warady BA et al. Anemia in pediatric hemodialysis patients: results from the 2001 ESRD Clinical Performance Measures Project. Kidney Int 2003; 64: 1120-1124
29. Cengiz N, Baskin E, Agras PI et al. Relationship between chronic inflammation and cardiovascular risk factors in children on maintenance hemodialysis. Transplant Proc 2005; 37: 2915-2917
30. Kalantar-Zadeh K, McAllister CJ, Lehn RS et al. Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis 2003; 42: 761-773
31. Gunnell J, Yeun JY, Depner TA et al. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 1999; 33: 63-72
32. Azhir A, Nasiri J, Gheisari A. Prevalence and severity of anemia in pediatric hemodialysis patients. Saudi Med J 2007; 28: 249-253
33. Seeherunvong W, Rubio L, Abitbol CL et al. Identification of poor responders to erythropoietin among children undergoing hemodialysis. J Pediatr 2001; 138: 710-714
34. Johnson ES, Thorp ML, Yang X et al. Predicting renal replacement therapy and mortality in CKD. Am J Kidney Dis 2007; 50: 559-565
35. Madore F, Lowrie EG, Brugnara C et al. Anemia in hemodialysis patients: variables affecting this outcome predictor. J Am Soc Nephrol 1997; 8: 1921-1929
36. Amaral S, Hwang W, Fivush B et al. Serum albumin level and risk for mortality and hospitalization in adolescents on hemodialysis. Clin J Am Soc Nephrol 2008; 3: 759-767
37. Krapf R, Hulter HN. Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA). Clin J Am Soc Nephrol 2009; 4: 470-480
38. Bamgbola OF. Pattern of resistance to erythropoietin-stimulating agents in chronic kidney disease. Kidney Int 2011; 80: 464-474
39. Port RE, Mehls O. Erythropoietin dosing in children with chronic kidney disease: based on body size or on hemoglobin deficit? Pediatr Nephrol 2009; 24: 435-437